AminahJatoiMD

Oncology • Rochester, MN

Professor, Oncology, Mayo Medical School

Join to view full profile

Dr. Jatoi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jatoi's full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-284-2511

Summary

Dr. Aminah Jatoi is an oncologist based in Rochester, MN, with extensive expertise in pancreatic cancer, gastrointestinal oncology, and general medical oncology. She completed her fellowship in Hematology and Medical Oncology at the University of Minnesota and her residency in Internal Medicine at Case Western Reserve University/University Hospitals Cleveland Medical Center, after graduating from the University of Texas Medical Branch School of Medicine in 1987. Her published works focus on a range of topics, including challenges in cancer cachexia research. Dr. Jatoi is actively involved in clinical trials, such as investigating treatments for loss of appetite in advanced cancer patients and assessing exercise for cancer patients at high fall risk.

Education & Training

University of MinnesotaFellowship, Hematology and Medical Oncology, 1990 - 1993
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1987 - 1990
University of Texas Medical Branch School of MedicineClass of 1987

Certifications & Licensure

MN State Medical License 1992 - 2026
TX State Medical License 1988 - 1999
American Board of Internal Medicine Medical Oncology

Clinical Trials

Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach Start of enrollment: 2000 Jan 01
Completed
Phase 2
Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-small Cell Lung Cancer Start of enrollment: 2000 Jan 01
Completed
Phase 2
Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 2000 Dec 01
Completed
Phase 2
Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer Start of enrollment: 2001 Feb 01
Completed
Phase 3
Ceramide Cream in Treating Women With Cutaneous Breast Cancer Start of enrollment: 2001 Jan 01
Completed
Phase 2
Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Start of enrollment: 2001 Apr 01
Completed
Phase 2
Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Start of enrollment: 2002 Jan 01
Completed
Phase 2
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite Start of enrollment: 2000 Mar 01
Completed
Phase 3
Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer Start of enrollment: 2002 May 01
Completed
Phase 3
Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer Start of enrollment: 2002 Sep 01
Completed
Phase 2
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) Start of enrollment: 2002 Oct 01
Completed
Phase 3
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer Start of enrollment: 2003 May 01
Completed
Phase 3
Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction Start of enrollment: 2003 Sep 01
Completed
Phase 2
Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer Start of enrollment: 2004 Oct 01
Completed
Phase 2
Lycopene in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2004 Jan 01
Completed
Phase 2
Creatine in Treating Patients With Cancer-Associated Weight Loss Start of enrollment: 2004 Dec 01
Completed
Phase 3
Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer Start of enrollment: 2004 Dec 01
Completed
Not Applicable
Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2005 Jul 01
Completed
Phase 2
Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction Start of enrollment: 2005 Aug 01
Completed
Phase 2
Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer Start of enrollment: 2006 Jan 01
Completed
Phase 2
Octreotide in Treating Patients With Cancer-Related Malignant Ascites Start of enrollment: 2005 Oct 01
Completed
Phase 3
Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery Start of enrollment: 2006 Apr 01
Terminated
Phase 2
Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer Start of enrollment: 2006 Oct 01
Completed
Phase 3
Nicotine in Treating "Hunger Pain" in Patients With Malignant Bowel Obstruction Caused By Cancer Start of enrollment: 2003 Dec 01
Withdrawn
Not Applicable
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer Start of enrollment: 2007 May 01
Completed
Phase 2
Capecitabine With or Without Sunitinib Malate as First-Line Therapy in Treating Patients With Metastatic Cancer of the Esophagus or Gastroesophageal Junction Start of enrollment: 2009 Aug 01
Completed
Phase 2
White Wine or Nutritional Supplement in Improving Appetite in Patients With Cancer Start of enrollment: 2009 Jul 01
Completed
Not Applicable
Menadione Topical Lotion in Treating Skin Discomfort and Psychological Distress in Patients With Cancer Receiving Panitumumab, Erlotinib Hydrochloride, or Cetuximab Start of enrollment: 2012 Jan 23
Active, not recruiting
Not Applicable
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer Start of enrollment: 2013 Mar 31
Terminated
Phase 3
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab Start of enrollment: 2012 Aug 31
Completed
Phase 2
Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery Start of enrollment: 2013 Oct 04
Active, not recruiting
Phase 2
Auranofin in Decreasing Pain in Patients With Paclitaxel-Induced Pain Syndrome Start of enrollment: 2014 Feb 19
Completed
Phase 2
Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer Start of enrollment: 2016 Feb 25
Active, not recruiting
Phase 1
Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin Start of enrollment: 2017 Jul 14
Active, not recruiting
Not Applicable
Auranofin and Sirolimus in Treating Participants With Ovarian Cancer Start of enrollment: 2018 Mar 30
Active, not recruiting
Phase 2
Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients Start of enrollment: 2018 May 25
Completed
Phase 4
Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced Rash Start of enrollment: 2018 Aug 22
Active, not recruiting
Early Phase 1
"Prescribing" Exercise to Cancer Patients at High-Risk for Falls Start of enrollment: 2020 Sep 03
Recruiting
Phase 1
Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer Start of enrollment: 2020 Nov 16
Active, not recruiting
Phase 2
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients Start of enrollment: 2022 Jan 03
Recruiting
Phase 3
Roles: Contact, Study Chair
Join now to see all

Publications & Presentations

PubMed

Association of age and performance status with adverse events in older adults with diffuse large B-cell lymphoma receiving frontline R-CHOP therapy: Alliance 151930, a...
Vicki A Morrison, Jennifer Le-Rademacher, Olivia Bobek, Daniel Satele, John P Leonard
Journal of Geriatric Oncology. 2025-01-13
Gender-Affirming Hormone Therapy for Breast Cancer in Transgender and Gender-Diverse Individuals: Unresolved and Unaddressed Issues.
Sanjna Rajput, Aminah Jatoi, Caroline Davidge-Pitts, Elizabeth J Cathcart-Rake
Mayo Clinic Proceedings. 2025-01-01
Many ways, one destination: a comprehensive review of screening and assessment tools to detect malnutrition in patients with ovarian cancer.
Diletta Fumagalli, Luigi A De Vitis, Roma Sonik, Aminah Jatoi, Amanika Kumar
International Journal of Gynecological Cancer. 2024-12-17

Journal Articles

Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer
Aminah Jatoi, Antonio C Wolff, Harvey Jay Cohen, Rachel A Freedman, Gustav Magrinat, Julie Gralow, Gretchen Kimmick, Heidi D Klepin, Harold Burstein, Hyman Muss, Jeann..., Journal of the American Geriatrics Society

Abstracts/Posters

Alliance A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (_ 70 Years...
Aminah Jatoi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Alliance A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (_ 70 Years...
Aminah Jatoi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Optimizing Management of Colorectal Cancer in Older Adults
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020
Preemptive versus reactive topical clobetasol for regorafenib-induced hand-foot reactions: Results from the ReDOS trial.
2019 ASCO Annual Meeting - 6/1/2019
Expanding the Scope of Precision Medicine: Integration of Patient Preference and Experience. Personalizing Care for Older Adults With Cancer: From Decision-Making to C...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Other

What Occurs in the Other 20% of Cancer Patients with Chemotherapy-Induced Nausea and Vomiting (CINV)? A Single-Institution Qualitative Study
Aminah Jatoi, MD, Supportive care in cancer
https://www.doximity.com/articles/00544396-d46d-4d22-b73b-618d01365161
UpToDate, Wolters Kluwer Health - 2012-06-08

Press Mentions

The Overlooked (And Weird) Symptom Many with Cancer HaveDecember 5th, 2022
Hiccups in Patients with Cancer Often Overlooked, UndertreatedNovember 16th, 2022
Hiccups in Patients with Cancer Often Overlooked, UndertreatedNovember 16th, 2022
Join now to see all